MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, T. M.
Right arrow Articles by Stiles, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, T. M.
Right arrow Articles by Stiles, G. L.

0026-895X/97/040632-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:632-640 (1997).

Induction of Multiple Effects on Adenylyl Cyclase Regulation by Chronic Activation of the Human A3 Adenosine Receptor

Timothy M. Palmer,1 Carol A. Harris, James Coote, and Gary L. Stiles

Departments of Medicine and Pharmacology, Duke University Medical Center, Durham, North Carolina 27710 (T.M.P., G.L.S.), and Glaxo Wellcome Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK (C.A.H., J.C.)

The A3 adenosine receptor (A3AR) contributes to several cardiovascular effects of adenosine, including antihypertensive and cardioprotective effects. Although several studies have detailed the mechanisms underlying agonist-mediated desensitization of the rat A3AR, the regulation of the human A3AR, which displays only a 70% amino acid identity with the rat homologue, has not been addressed. Using a Chinese hamster ovary cell line stably expressing a recombinant human A3AR, we demonstrated that prolonged treatment with the AR agonist 5'-N-ethylcarboxamidoadenosine induces uncoupling of the A3AR from G proteins and functional desensitization. In addition to A3AR desensitization, a 1.5-2.5-fold increase was noted in the adenylyl cyclase (AC) activity achieved in the presence of GTP with or without forskolin. This sensitization of AC activity was not a consequence of the down-regulation of Gi proteins induced by NECA treatment and was not associated with sustained or transient increases in the expression of Gs. Time course experiments revealed that the onset of sensitization was half-maximal between 2 and 3 hr but was not due to the synthesis of new proteins because cycloheximide treatment failed to inhibit sensitization. The inability of the sensitization process to alter the AC activity obtained in the presence of manganese chloride suggests that prolonged A3AR activation increases the coupling efficiency between Gs and AC catalytic units. This phenomenon has implications for long term cellular adaptation to agonist because in agonist-treated cells, the extent to which a suboptimal concentration of forskolin could increase phosphorylation of the cAMP-responsive element binding protein was elevated compared with vehicle-treated controls.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Immunol.Home page
O. Levy, M. Coughlin, B. N. Cronstein, R. M. Roy, A. Desai, and M. R. Wessels
The Adenosine System Selectively Inhibits TLR-Mediated TNF-{alpha} Production in the Human Newborn
J. Immunol., August 1, 2006; 177(3): 1956 - 1966.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. E. Culm and R. P. Hammer Jr.
Recovery of Sensorimotor Gating without G Protein Adaptation after Repeated D2-Like Dopamine Receptor Agonist Treatment in Rats
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 487 - 494.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. L. Trincavelli, D. Tuscano, M. Marroni, A. Falleni, V. Gremigni, S. Ceruti, M. P. Abbracchio, K. A. Jacobson, F. Cattabeni, and C. Martini
A3 Adenosine Receptors in Human Astrocytoma Cells: Agonist-Mediated Desensitization, Internalization, and Down-Regulation
Mol. Pharmacol., December 1, 2002; 62(6): 1373 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. J. Watts
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 1 - 7.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv., June 1, 2002; 2(3): 168 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. G. Cumbay and V. J. Watts
Heterologous Sensitization of Recombinant Adenylate Cyclases by Activation of D2 Dopamine Receptors
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1201 - 1209.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
M. L. Bayewitch, I. Nevo, T. Avidor-Reiss, R. Levy, W. F. Simonds, and Z. Vogel
Alterations in Detergent Solubility of Heterotrimeric G Proteins after Chronic Activation of Gi/o-Coupled Receptors: Changes in Detergent Solubility Are in Correlation with Onset of Adenylyl Cyclase Superactivation
Mol. Pharmacol., April 1, 2000; 57(4): 820 - 825.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics